XML 89 R65.htm IDEA: XBRL DOCUMENT v3.20.4
Equity Compensation Plans and Share-Based Compensation - Restricted Stock Unit Award Activity (Details) - $ / shares
shares in Thousands
1 Months Ended 12 Months Ended
Dec. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Underlying Shares - Outstanding at beginning of year   357 254 157
Underlying Shares - Outstanding at end of year 373 373 357 254
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Weighted-Average Exercise Price - Outstanding at beginning of year   $ 69.13 $ 59.53 $ 47.36
Weighted-Average Exercise Price - Outstanding at end of year $ 77.40 $ 77.40 $ 69.13 $ 59.53
Performance Shares [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Underlying Shares - Granted   238 109 102
Underlying Shares - Exercised   (117) (10) (10)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Weighted-Average Exercise Price - Granted   $ 78.40 $ 86.86 $ 72.70
Weighted-Average Exercise Price - Vested   $ 48.25 $ 45.93 $ 45.93
Vesting period   3 years    
Time Based Shares        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Underlying Shares - Granted   21 19 17
Underlying Shares - Exercised   (12) (15) (12)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Weighted-Average Exercise Price - Granted   $ 84.93 $ 86.86 $ 72.70
Weighted-Average Exercise Price - Vested   $ 76.84 $ 73.78 $ 43.55
Vesting period   5 years 5 years 5 years
Performance-Based Canceled        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Underlying Shares - Exercised   (114) 0 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Weighted-Average Exercise Price - Vested   $ 84.93 $ 0 $ 0
Grant date fair value of replacement performance-based awards $ 72.37